Delivery Order SPE2DR25D3103-SPE2DR26F9P18
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for potassium chloride 10 mEq/100 mL solution in 100 mL quantities, valued at $1,192.10. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,348,112 units of Potassium Chloride 10% (20 mEq/15 mL) in 15 mL cups. The $3,213.00 delivery order has a completion date of January 18, 2024. AmerisourceBergen Drug Corp, as a prime contractor, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units, valued at $3,505.19. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of 4564222331 - Potassium Chloride ER 20 MEQ Tablets, 500 count, with a completion date of April 10, 2024 and a ceiling value of $1,161.32. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,192.10 for the supply of potassium chloride 10 MEQ/100 mL solution. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,474.28 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 100. This non-set-aside, firm fixed price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,941.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, carries an ultimate completion date of August 12, 2025, and will be performed at the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Potassium Cl 10% (20meq/15ml) Cup UD 15ml. The $1,137.68 contract has a completion date of January 23, 2024 and was awarded on January 22, 2024. Amerisourcebergen Drug Corp is a For Profit Organization that provides pharmaceutical products and services to U.S. government agencies, primarily the Department...
- The Defense Logistics Agency awarded a $5,932.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units, with performance completion targeted for March 17, 2025. This non-set-aside competitive award is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,184.64 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and no set-aside designation was used in the award. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P18Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order from the Defense Logistics Agency (DLA) on December 12, 2025, for the supply of Potassium Chloride 10% (20 mEq/15mL) in unit dose cups totaling $1,030.77. This is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 15, 2025. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant presence in federal medical procurement and has demonstrated capability to meet competitive procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/11/25 |